These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33651675)

  • 1. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 2. REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamics.
    Kamal MA; Dingman R; Wang CQ; Lai CH; Rajadhyaksha M; DeVeaux M; Orengo JM; Radin A; Davis JD
    Clin Transl Sci; 2021 Nov; 14(6):2440-2449. PubMed ID: 34437752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit.
    de Blay FJ; Gherasim A; Domis N; Meier P; Shawki F; Wang CQ; Orengo JM; DeVeaux M; Ramesh D; Jalbert JJ; Kamal MA; Abdallah H; Dingman R; Perlee L; Weinreich DM; Herman G; Yancopoulos GD; O'Brien MP
    J Allergy Clin Immunol; 2022 Dec; 150(6):1437-1446. PubMed ID: 35934082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.
    Satyaraj E; Wedner HJ; Bousquet J
    Allergy; 2019 Oct; 74 Suppl 107(Suppl 107):5-17. PubMed ID: 31498459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.
    Eckman JA; Sterba PM; Kelly D; Alexander V; Liu MC; Bochner BS; Macglashan DW; Saini SS
    J Allergy Clin Immunol; 2010 Apr; 125(4):889-895.e7. PubMed ID: 19962744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.
    Klunker S; Saggar LR; Seyfert-Margolis V; Asare AL; Casale TB; Durham SR; Francis JN;
    J Allergy Clin Immunol; 2007 Sep; 120(3):688-95. PubMed ID: 17631952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood--report of the German Multicentre Allergy Study (MAS 90).
    Lau S; Illi S; Platts-Mills TA; Riposo D; Nickel R; Grüber C; Niggemann B; Wahn U;
    Allergy; 2005 Jun; 60(6):766-73. PubMed ID: 15876306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract.
    Nanda A; O'connor M; Anand M; Dreskin SC; Zhang L; Hines B; Lane D; Wheat W; Routes JM; Sawyer R; Rosenwasser LJ; Nelson HS
    J Allergy Clin Immunol; 2004 Dec; 114(6):1339-44. PubMed ID: 15577832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.
    Pène J; Desroches A; Paradis L; Lebel B; Farce M; Nicodemus CF; Yssel H; Bousquet J
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):571-8. PubMed ID: 9802364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol plus carboxymethyl-β-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis.
    Miraglia Del Giudice M; Maiello N; Capristo C; Alterio E; Capasso M; Perrone L; Ciprandi G
    Curr Med Res Opin; 2014 Oct; 30(10):1931-5. PubMed ID: 24983742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects.
    Simons FE; Imada M; Li Y; Watson WT; HayGlass KT
    Int Immunol; 1996 Dec; 8(12):1937-45. PubMed ID: 8982778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.
    Tasaniyananda N; Chaisri U; Tungtrongchitr A; Chaicumpa W; Sookrung N
    PLoS One; 2016; 11(3):e0150463. PubMed ID: 26954254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major cat allergen (Fel d I) levels in the homes of patients with asthma and their relationship to sensitization to cat dander.
    Quirce S; Dimich-Ward H; Chan H; Ferguson A; Becker A; Manfreda J; Simons E; Chan-Yeung M
    Ann Allergy Asthma Immunol; 1995 Oct; 75(4):325-30. PubMed ID: 7583847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.